MSHP 2011 Midyear Clinical Meeting
September 16, 2011
Earle Brown Heritage Center
Brooklyn Center, Minnesota
“Transforming Pharmacy’s Role on the Patient Care Team”
Agenda/Speakers/CE Hours/ACPE Numbers/Objectives
Friday, September 16th
Total
Time Hours Speaker/Presentation Title
8:15 – 9:15 a.m. 1 hour Kit Welchlin
“You’re on a Team, You May as Well be Good at It”
0134-0000-11-093-L04-P; 0134-0000-11-093-L04-T
Pharmacist Learning Objectives:
1. Review the requirements needed to build a multidisciplinary healthcare team to successfully optimize patient care
2. Describe the tools needed for successful multidisciplinary team meetings in the healthcare setting
3. Develop strategies to build a successful multidisciplinary healthcare team that includes pharmacy
4. Identify the essentials to build cohesiveness between the pharmacist and the other members of a multidisciplinary healthcare team
5. Review techniques to effectively deal with disagreement between members of the multidisciplinary healthcare team
6. Discuss techniques to successfully repair relationships between members of the multidisciplinary healthcare team
Technician Learning Objectives:
1. Identify the rules of sensible self-disclosure as part of a multidisciplinary healthcare team
2. Discuss methods to develop and maintain trust as a pharmacy member of a multidisciplinary healthcare team
3. Review verbal and non-verbal techniques to effectively express opinions and concerns while functioning on a multidisciplinary healthcare team
4. Identify conflict resolution skills and negotiation strategies to become a successful member of a multidisciplinary healthcare team
10:00 – 11:00 Noon 1 hour “Preventing Stroke in Atrial Fibrillation: Overview of New and Emerging Antithrombotic Agents and Roles for Pharmacist”
**ASHP Advantage- ACPE accreditation provided by ASHP**
(http://ce.ashp.org)
10:00 – 11:00 a.m. 1 hour Bruce Thompson
“Pharmacy’s Role in Improving Patient Care through an Accountable Care
Organization”
0134-0000-11-094-L04-P; 0134-0000-11-094-L04-T
Pharmacist Learning Objectives:
1. Describe the concepts of an Accountable Care Organization
2. Identify steps to consider reducing patient readmission from a pharmacy perspective
3. Adopt the process to develop new services
4. Provide options to gain approval of MTM services
5. To differentiate roles in the ACO
6. Explain the transition to ACO
Total
Time Hours Speaker/Presentation Title
Technician Program Learning Objectives:
1. Describe the concepts of an Accountable Care Organization
2. Learn the roles of Technicians to support pharmacy services in Acute care
3. Define the role of Community Pharmacy Technicians in an ACO
4. Identify the opportunities for technicians in Ambulatory practice
10:00 – 11:00 a.m. 1 hour Steven Kastendieck
“Implementing USP 797/795 Best Practices to Ensure Patient Safety and
Quality”
0134-0000-11-095-L01-P; 0134-0000-11-095-L01-T
Pharmacist Learning Objectives:
1. Explain the relationship of USP 797/795 too Minnesota Pharmacy rules.
2. Differentiate between the provisions of USP 797 vs USP 795.
3. Explain the challenges in planning and implementing engineering controls for anteroom, buffer room and hazardous buffer room.
4. Describe the purpose of quality control monitoring including surface sampling, fingertip sampling, airborne particulates and airborne viable particulates.
5. Identify NIOSH best practices for the safe handling of hazardous oral solids.
6. Describe the record-keeping requirements for non-sterile compounding.
Technician Program Learning Objectives:
1. Discuss the importance of the attire and personal protective equipment worn in sterile and non-sterile compounding.
2. Describe the purpose of quality control monitoring including surface sampling, fingertip sampling, airborne particulates and airborne viable particulates.
3. Identify NIOSH best practices for the safe handling of hazardous oral solids.
4. Describe the record-keeping requirements for non-sterile
compounding.
11:00 – 12:00 p.m. 1 hour Christine Borscheid and Emily Medcraft
“Caring for the Solid Organ Transplant Patient”
0134-0000-11-096-L01-P; 0134-0000-11-096-L01-T
Pharmacist Learning Objectives: 1. To discuss the prevalence of abdominal solid organ transplants
2. To identify commonly used immunosuppressant medications
3. To evaluate drug interactions with immunosuppressant medications and other commonly used medications in transplant patients.
4. To recognize common side effects of immunosuppressant medications and discuss management strategies.
5. To describe differences and administration of immunosuppressant product formulations
6. To distinguish basic care principles and potential complications unique to the solid organ transplant patient
Technician Program Learning Objectives:
1. To discuss the prevalence of abdominal solid organ transplants
2. To identify commonly used immunosuppressant medications.
3. To describe differences and administration of immunosuppressant product formulations
4. To discuss potential long term complications associated with transplant and immunosuppressant medications
Total
Time Hours Speaker/Presentation Title
11:00 – 12:00 p.m. 1 hour Shane Madsen and Cody Wiberg
“Protecting the Public: MSHP Advocacy and Board of Pharmacy Update”
0134-0000-11-097-L05-P; 0134-0000-11-197-L05-T
Pharmacist Learning Objectives:
Cody Wiberg’s Objectives:
1. Describe recent rule changes involving pharmacy licensing categories
2. Describe recent rule changes involving automated drug distribution systems
3. Describe recent rule changes involving automated counting devices
4. Describe recent changes in Minnesota Statutes concerning controlled substances
5. List the legislative issues that the Board of Pharmacy is likely to pursue in 2012
6. List likely rule changes that the Board of Pharmacy is considering
Shane Madsen’s Objectives:
1. Discuss the current public policy / advocacy agenda for ASHP
2. Define how the practice of Pharmacy in the State of Minnesota is affected by the advocacy agenda of ASHP.
3. Challenge pharmacists in Minnesota to more actively engage in Public Policy issues in our state.
Technician Program Learning Objectives:
Cody Wiberg’s Objectives:
1. Describe recent rule changes involving registration of technicians
2. Describe recent rule changes involving technicians and the use of IVR
Systems
3. Describe recent rule changes involving technicians and extemporaneous compounding
4. Describe the new continuing education requirements for technicians
Shane Madsen’s Objectives:
1. Discuss the key areas affecting technicians as it relates to the ASHP advocacy agenda.
2. Discuss how the role of the technician can be affected by the ASHP advocacy agenda
3. Challenge technicians in Minnesota to more actively engage in Public Policy issues in our state
1:15 – 2:15 p.m. 1 hour “Pearls-Clinical, Administrative, Technicians”
Clinical Pearls
0134-0000-11-098-L04-P; 0134-0000-11-098-L04-T
Janna Afanasjeva: “Drug-induced Eosinophilic Pneumonia: Brief Review
Pharmacists Objectives:
1. Describe the potential use for procalcitionin in the hospital setting in order to help reduce antibiotic exposure.
Technician Objectives:
1. Define drug-induced eosinophilic pneumonia
Bernard Lee/Ebony Ayres: “What’s in the Box? True Interpretations of Select Pediatric Black Box Warnings”
Pharmacists Objectives:
2. Critically evaluate the clinical interpretations of FDA labeled pediatric black box warnings for fluoroquinolones, long acting beta agonists, and selective serotonin reuptake inhibitors.
Total
Time Hours Speaker/Presentation Title
Technician Objectives:
2. Discuss current FDA labeled pediatric black box warnings for fluoroquinolones, long acting beta agonists, and selective serotonin reuptake inhibitors.
Kelly Considine: “Procalcitonin: A biomarker to potentially reduce antibiotic exposure”
Pharmacists Objectives:
3. Describe the potential use for procalcitonin in the hospital setting in order to help reduce antibiotic exposure.
Technician Objectives:
3. Describe the relationship between procalcitionin levels and bacterial infections.
Ann Foede: “Ceftaroline: A New Cephalosporin”
Pharmacists Objectives:
4. Discuss ceftaroline’s role in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections.
Technician Objectives:
4. Explain how ceftaroline differs from other cephalosporins.
Joel Peterson: “Pharmacologic Management of the Shivering Response in Therapeutic Hypothermia”
Pharmacists Objectives:
5. Recommend an appropriate pharmacologic agent to mitigate the shivering response in therapeutic hypothermia.
Technician Objectives:
5. Identify pharmacologic agents used to mitigate the shivering response in therapeutic hypothermia.
1:15 – 2:15 p.m. 1 hour “Pearls-Clinical, Administrative, Technicians”
Non-Clinical Pearls
0134-0000-11-099-L04-P; 0134-0000-11-099-L04-T
Reid Horning: “Implementing 340B drug purchasing at a critical access hospital”
Pharmacists Objectives:
1. Describe the purpose of the 340B program. Describe the key steps to implement the 340B program at a critical access hospital
Technician Objectives:
1. Describe the process for implementing a 340B program at a critical access hospital.
George Konstantinides: “Sometimes what you do in private should be just that, private: E-Professionalism overview”
Pharmacists Objectives:
2. Summarize the dilemma faced in today’s technology driven world regarding social medial and outline the results of two studies focusing specifically on social media and pharmacy students/residency program directors.
Technician Objectives:
2. Evaluate the dilemma faced by today’s technology driven world and the level of professionalism required for those in the pharmacy profession.
Paul Krogh: “Development of a data driven process to assist in flexing of staffing requirements on a day-to-day basis”
Pharmacists Objectives:
3. Describe the development of a data driven process to assist in flexing of staffing requirements on a day-to-day basis.
Total
Time Hours Speaker/Presentation Title
4. Explain what the flexing model provides, and does not provide, in regards to pharmacist “workload” monitoring
5. Describe other data points used to assist in flexing of staffing requirements.
Technician Objectives:
3. Describe the data-driven process to assist with flexing staff to support pharmacy workload
Kathryn Perrotta: “Development of a Dietary Supplement Formulary for Inpatient Hospital Use”
Pharmacists Objectives:
6. Describe the limitations of dietary supplements and the rational steps to developing an inpatient dietary supplement formulary.
Technician Objectives:
4. Describe the challenges encountered when developing a formulary for dietary supplements.
Jamie Sinclair: “A case for change: Why do we need to improve quality?
Pharmacists Objectives:
7. Outline the economic and social consequences of sub-standard medication use or pharmacy practice.
Technician Objectives:
5. Describe the potential outcomes from a sub-standard medication use process.
2:30 – 3:30 p.m. 1 hour Melissa Carlson and Adam Gregg
“Preceptor Development: Precepting the Pharmacists of Tomorrow”
0134-0000-11-100-L04-P; 0134-0000-11-100-L04-T
Program Learning Objectives:
1. Describe rationale to support need for ongoing preceptor development
2. Identify skills and traits of successful pharmacist preceptors.
3. Formulate rationale & achievable goals for developing preceptor skills
4. Compare and contrast peer-implemented strategies for promoting preceptor development
5. Identify external resources available to supplement and guide preceptor development activities
6. Devise a personal strategy for a continual professional development plan as a pharmacist or technician preceptor
Technician Program Learning Objectives:
1. Describe rationale to support need for ongoing technician preceptor development
2. Identify skills and traits of successful technician preceptors
3. Compare and contrast peer-implemented strategies for promoting technician preceptor development
4. Identify external resources available to supplement and guide technician preceptor development activities
2:30– 3:30 p.m. 1 hour Krista Gens, Matthew Ditmore, Katherine Hines,
Anne Spenningsby and Kari Ann Torma
“Nabbing Your Dream Job: Letter of Intent and Interviewing Skills”
0134-0000-11-101-L04-P; 0134-0000-11-101-L04-T
Pharmacist Learning Objectives:
1. To identify the key elements of a letter of intent for pursuing a
pharmacist position
2. To distinguish oneself from other pharmacist applicants in a letter of
intent.
3. To easily prepare a letter of intent for residency or your first
pharmacist position
4. To persuade a potential employer to see your unique pharmacist qualities as essential
Total
Time Hours Speaker/Presentation Title
5. To avoid common pharmacist or residency interview pitfalls. 6. To respond appropriately to typical pharmacist or residency interview questions
Technician Program Learning Objectives:
1. To identify the key elements of a letter of intent for pursuing a pharmacy position
2. To easily prepare a pharmacy technician letter of intent
3. To avoid common pharmacy interview pitfalls
4. To respond appropriately to typical pharmacy interview questions
2:30 – 3:30 p.m. 1 hour Tamara Bezdicek and Kristen Melius
“A Team Approach to the Care of the CRRT Patient”
0134-0000-11-102-L01-P; 0134-0000-11-102-L01-T
Pharmacist Learning Objectives:
1. Describe what type of patients continuous renal replacement therapy (CRRT) is initiated in and goals of therapy
2. Explain how CRRT differs from other types of dialysis and the
different CRRT modalities
3. Identify what types of resources are utilized for CRRT patients
and the impact on the pharmacy department
4. Describe safety issues and complications of CRRT and how to
manage them
5. Describe barriers to CRRT and strategies used to overcome them
6. Outline the multidisciplinary team approach to CRRT
Technician Learning Objectives:
1. Describe why patients are placed on continuous renal replacement
therapy
2 Explain the differences between CRRT and conventional dialysis
3. Explain CRRT dialysate and replacement fluid distribution and
purchasing
4. Outline the many disciplines involved in caring for the CRRT patient
3:30 - 5:00 p.m. 1.5 hours “A Pharmacist’s Roadmap to Pain Management: New Directions to Improved Patient Care”
**ACPE Accreditation provided through Vemco MedEd, LLC**
3:30 – 4:30 p.m. 1 hour Dottie Gee and Denise Deutsch
“Successful Integration of a Comprehensive Pharmaceutical Waste Management Program in a Healthcare Environment”
0134-0000-11-103-L04-P; 0134-0000-11-103-L04-T
Pharmacist Learning Objectives:
1. Identify rules and regulations that apply to pharmaceutical waste
2. Discuss the issues and concerns surrounding pharmaceutical waste
3. Discuss common hazardous waste regulatory inspection issues
4. Explain how Joint Commission is involved with pharmaceutical waste
5. Integrate pharmaceutical waste into your organizational culture
6. Outline key elements to training staff on a Pharmaceutical Waste
Program
Technician Program Learning Objectives:
1. Recognize rules and regulations that apply to pharmaceutical waste
2. Summarize issues and concerns surrounding pharmaceutical waste
3. Integrate pharmaceutical waste into your organizational culture
4. Outline key elements to training staff on a Pharmaceutical Waste
Program
ACPE Credits:
13.5 Total Credit Hours (Note: 2 Credits provided by Massachusetts College of Pharmacy & Health Sciences)
6.5 Total Available Hours
1